Literature DB >> 21452415

Long-term renal function in children after liver transplantation.

Jesper M Kivelä1, Anne Räisänen-Sokolowski, Mikko P Pakarinen, Heikki Mäkisalo, Hannu Jalanko, Christer Holmberg, Jouni Lauronen.   

Abstract

BACKGROUND: Reduced renal function after liver transplantation (LT) is a long-term extrahepatic complication of major concern caused at least partly by calcineurin inhibitor nephrotoxicity. We report on long-term renal function after LT in children from a single center and analyze the usefulness of glomerular filtration rate (GFR) estimation methods in the follow-up of pediatric LT patients.
METHODS: Fifty-seven pediatric patients were included. GFRs were measured by 51-labeled chromium ethylenediaminetetraacetic acid clearance before LT, at discharge, 6, 12, 18, and 24 months after transplantation and annually thereafter and corrected with the modified Brochner-Mortensen equation. GFR values of cases with an ethylenediaminetetraacetic acid distribution volume less than 15% or more than 35% were excluded.
RESULTS: The mean GFR for overall follow-up was 76.0 mL/min/1.73 m2 (+/-22.2 mL/min/1.73 m2). The GFR declined significantly from 5 to 7 years (80.2 [+/-17.7] to 72.9 [+/-13.3] mL/min/1.73 m2, respectively; P<0.05). Thirteen percent, 21%, 31%, and 33% of patients had stage 3 chronic kidney disease at 5, 7, 10, and 15 years after LT, respectively. The cyclosporine A trough level was a significant time-dependent factor in the regression model, and after time was removed from the model, proteinuria was the most significant factor. GFR estimation methods overestimated measured GFR; 11% with updated Schwartz, 50% with Schwartz 1987, and 31% with Counahan-Barratt.
CONCLUSIONS: This study underlines the importance of long-term renal function surveillance after LT performed on children. Although measuring GFR remains the preferred function surveillance method, the updated Schwartz formula is also acceptable.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21452415     DOI: 10.1097/tp.0b013e3181fa94b9

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Molecular therapy of primary hyperoxaluria.

Authors:  Cristina Martin-Higueras; Armando Torres; Eduardo Salido
Journal:  J Inherit Metab Dis       Date:  2017-04-19       Impact factor: 4.982

2.  Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicity.

Authors:  Yuxia Cui; Qihong Huang; James Todd Auman; Brian Knight; Xidong Jin; Kerry T Blanchard; Jeff Chou; Supriya Jayadev; Richard S Paules
Journal:  Toxicol Sci       Date:  2011-08-24       Impact factor: 4.849

3.  Risk factors for end-stage kidney disease after pediatric liver transplantation.

Authors:  R L Ruebner; P P Reese; M R Denburg; E B Rand; P L Abt; S L Furth
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

4.  Accuracy of different equations in estimating GFR in pediatric kidney transplant recipients.

Authors:  Vandréa de Souza; Pierre Cochat; Muriel Rabilloud; Luciano Selistre; Mario Wagner; Aoumeur Hadj-Aissa; Olga Dolomanova; Bruno Ranchin; Jean Iwaz; Laurence Dubourg
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-23       Impact factor: 8.237

Review 5.  The Kidney in Pediatric Liver Disease.

Authors:  Robyn Greenfield Matloff; Ronen Arnon
Journal:  Curr Gastroenterol Rep       Date:  2015-09

6.  Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review.

Authors:  Ruiming Cai; Minzhuang Lin; Zhiyong Chen; Yongtong Lai; Xianen Huang; Guozhi Zhao; Xuekun Guo; Zhongtang Xiong; Juan Chen; Hui Chen; Qingping Jiang; Shaoyan Liu; Yuexin Yang; Weixiang Liang; Minhui Zou; Tao Liu; Wenfang Chen; Hongzhou Liu; Juan Peng
Journal:  BMC Nephrol       Date:  2019-06-18       Impact factor: 2.388

7.  Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus.

Authors:  Karel Vondrak; Francesco Parisi; Anil Dhawan; Ryszard Grenda; Nicholas J A Webb; Stephen D Marks; Dominique Debray; Richard C L Holt; Alain Lachaux; Deirdre Kelly; Gbenga Kazeem; Nasrullah Undre
Journal:  Clin Transplant       Date:  2019-09-19       Impact factor: 2.863

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.